Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea

Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and C...

Full description

Saved in:
Bibliographic Details
Published inEndocrinology and metabolism (Seoul) Vol. 36; no. 3; pp. 688 - 696
Main Authors Park, Jin Sun, Yun, Soo Jin, Lee, Jung Kuk, Park, So Young, Chin, Sang Ouk
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Endocrine Society 01.06.2021
대한내분비학회
Subjects
Online AccessGet full text
ISSN2093-596X
2093-5978
2093-5978
DOI10.3803/EnM.2021.1000

Cover

Abstract Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment. The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly. Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate.
AbstractList Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment.BACKGROUNDOnly a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment.The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used.METHODSThe nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used.The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly.RESULTSThe 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly.Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate.CONCLUSIONOverall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate.
Background Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing’s disease and their survival analysis according to treatment. Methods The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing’s disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. Results The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing’s disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing’s disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing’s disease ameliorated the survival rate significantly. Conclusion Overall, the incidence of prolactinoma and Cushing’s disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing’s disease for improving the survival rate.
Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment. The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly. Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate.
Background: Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing’s disease and their survival analysis according to treatment. Methods: The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing’s disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. Results: The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing’s disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing’s disease. The survival benefit was insignificant in prolactinoma according to treatment, but the treatment of Cushing’s disease improved the survival rate significantly. Conclusion: Overall, the incidence of prolactinoma and Cushing’s disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing’s disease for improving the survival rate. KCI Citation Count: 0
Author Park, Jin Sun
Lee, Jung Kuk
Chin, Sang Ouk
Park, So Young
Yun, Soo Jin
Author_xml – sequence: 1
  givenname: Jin Sun
  orcidid: 0000-0001-8831-8344
  surname: Park
  fullname: Park, Jin Sun
– sequence: 2
  givenname: Soo Jin
  surname: Yun
  fullname: Yun, Soo Jin
– sequence: 3
  givenname: Jung Kuk
  surname: Lee
  fullname: Lee, Jung Kuk
– sequence: 4
  givenname: So Young
  surname: Park
  fullname: Park, So Young
– sequence: 5
  givenname: Sang Ouk
  orcidid: 0000-0001-5914-3653
  surname: Chin
  fullname: Chin, Sang Ouk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34218648$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002728715$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptks9u1DAQhy1UREvpkSvKEQ5Z_C-Jc0FabZeyoggEReJmBmeydZvYi52stLe-Bq_Hk-DdbSuKuNiW55tvLPn3lBw475CQ54xOhKLi9dx9mHDK2YRRSh-RI05rkRd1pQ7uz-W3Q3IS41UCqFKScfaEHArJmSqlOiLfTzGaYFeDXWM2X9kGe-s7v9xk4JrsyxjWdg1dNnXQbaKNmW-zT8F3YAbrfA9xh83GeGnd8vfNr5id2ogQMbMue-8DwjPyuIUu4sntfky-vp1fzN7l5x_PFrPpeW6kqoYclGgZr3jJagOmKXlrFLQUC25okyqpqqgRtVIKOU1w2UrJWAMVQ0AEcUxe7b0utPraWO3B7val19dBTz9fLHRdc8rqIrGLPdt4uNKrYHsIm13D7sKHpYYwWNOhVmhqYVgpyqKWIBkYrKSivGpMVdWVTK43e9dq_NFjY9ANAboH0ocVZy_Tm9Za8UIJrpLg5a0g-J8jxkH3NhrsOnDox6h5IVWZFsoT-uLvWfdD7r4zAWIPmOBjDNhqYwcYrN-Otp1mVG9zo1Nu9DY3epub1JX_03Un_j__B4iZxKQ
CitedBy_id crossref_primary_10_1210_endrev_bnac010
crossref_primary_10_1001_jama_2023_11305
crossref_primary_10_1016_j_eprac_2024_10_016
Cites_doi 10.1210/jc.86.1.117
10.1530/eje-14-0144
10.7326/0003-4819-130-10-199905180-00015
10.1007/s11102-012-0454-0
10.1016/s0025-6196(12)60417-0
10.1111/cen.12020
10.1530/eje-07-0358
10.1210/jc.2006-1668
10.1677/erc.0.0080287
10.1530/eje-16-0117
10.1007/s11102-015-0701-2
10.1530/eje.0.1510439
10.1530/eje-13-1031
10.1210/jcem.84.8.5896
10.1016/b978-0-444-59602-4.00011-3
10.1210/jc.85.4.1420
10.1093/ije/dyw253
10.1210/jcem-62-6-1173
10.1007/bf03344942
10.1007/s11102-015-0655-4
10.1111/j.0954-6820.1988.tb15881.x
10.1007/s11102-020-01084-6
10.1530/eje-15-0189
10.1111/j.1365-2265.2009.03667.x
10.1590/2359-3997000000195
10.1111/j.1365-2265.1994.tb02486.x
10.1210/jc.2010-0537
ContentType Journal Article
Copyright Copyright © 2021 Korean Endocrine Society 2021
Copyright_xml – notice: Copyright © 2021 Korean Endocrine Society 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
ACYCR
DOI 10.3803/EnM.2021.1000
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2093-5978
EndPage 696
ExternalDocumentID oai_kci_go_kr_ARTI_9920195
oai_doaj_org_article_8ec93c1636594a41ace748027dc77974
PMC8258328
34218648
10_3803_EnM_2021_1000
Genre Journal Article
GroupedDBID 5-W
53G
5VS
8JR
8XY
AAYXX
ABDBF
ACUHS
ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EF.
GROUPED_DOAJ
HYE
HZB
KQ8
M48
OK1
PGMZT
RPM
ADRAZ
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c487t-a83f1272619cacd62fc8af0e52c0df123f180c39888e2083f6f4411da71eaeea3
IEDL.DBID M48
ISSN 2093-596X
2093-5978
IngestDate Sun Mar 09 07:54:20 EDT 2025
Wed Aug 27 01:32:15 EDT 2025
Thu Aug 21 18:02:53 EDT 2025
Fri Jul 11 00:38:49 EDT 2025
Wed Feb 19 02:27:27 EST 2025
Tue Jul 01 01:37:48 EDT 2025
Thu Apr 24 23:13:48 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Pituitary ACTH hypersecretion
Prolactinoma
Survival analysis
Prevalence
Epidemiology
Incidence
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c487t-a83f1272619cacd62fc8af0e52c0df123f180c39888e2083f6f4411da71eaeea3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current affiliation: Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
ORCID 0000-0001-5914-3653
0000-0001-8831-8344
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3803/EnM.2021.1000
PMID 34218648
PQID 2548625402
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9920195
doaj_primary_oai_doaj_org_article_8ec93c1636594a41ace748027dc77974
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8258328
proquest_miscellaneous_2548625402
pubmed_primary_34218648
crossref_citationtrail_10_3803_EnM_2021_1000
crossref_primary_10_3803_EnM_2021_1000
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-06-01
PublicationDateYYYYMMDD 2021-06-01
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-06-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Endocrinology and metabolism (Seoul)
PublicationTitleAlternate Endocrinol Metab (Seoul)
PublicationYear 2021
Publisher Korean Endocrine Society
대한내분비학회
Publisher_xml – name: Korean Endocrine Society
– name: 대한내분비학회
References ref13
ref12
ref15
ref14
ref11
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
(ref31) 2015
ref24
ref23
ref26
Harris (ref28) 1989
Ritchie (ref22) 1990
ref25
ref20
ref21
ref27
ref29
ref8
ref7
ref9
ref3
Ezzat (ref30) 2004
ref6
ref5
Park (ref4) 2015
References_xml – volume-title: Rare intractable pituitary diseases: analysis on their epidemiology and use of benefit extension policy (No. 2015-20-025)
  year: 2015
  ident: ref4
– ident: ref24
  doi: 10.1210/jc.86.1.117
– volume-title: National Health Insurance System of Korea [Internet]
  year: 2015
  ident: ref31
– ident: ref9
  doi: 10.1530/eje-14-0144
– ident: ref26
  doi: 10.7326/0003-4819-130-10-199905180-00015
– ident: ref7
  doi: 10.1007/s11102-012-0454-0
– ident: ref29
  doi: 10.1016/s0025-6196(12)60417-0
– ident: ref20
  doi: 10.1111/cen.12020
– ident: ref16
  doi: 10.1530/eje-07-0358
– ident: ref1
  doi: 10.1210/jc.2006-1668
– ident: ref12
  doi: 10.1677/erc.0.0080287
– ident: ref14
  doi: 10.1530/eje-16-0117
– ident: ref17
  doi: 10.1007/s11102-015-0701-2
– ident: ref21
  doi: 10.1530/eje.0.1510439
– ident: ref11
  doi: 10.1530/eje-13-1031
– ident: ref23
  doi: 10.1210/jcem.84.8.5896
– ident: ref10
  doi: 10.1016/b978-0-444-59602-4.00011-3
– ident: ref3
  doi: 10.1210/jc.85.4.1420
– start-page: 55
  volume-title: Ascertainment and natural history of treated acromegaly in Northern Ireland
  year: 1990
  ident: ref22
– ident: ref32
  doi: 10.1093/ije/dyw253
– ident: ref27
  doi: 10.1210/jcem-62-6-1173
– ident: ref18
  doi: 10.1007/bf03344942
– ident: ref19
  doi: 10.1007/s11102-015-0655-4
– ident: ref15
  doi: 10.1111/j.0954-6820.1988.tb15881.x
– ident: ref25
  doi: 10.1007/s11102-020-01084-6
– ident: ref13
  doi: 10.1530/eje-15-0189
– ident: ref6
  doi: 10.1111/j.1365-2265.2009.03667.x
– start-page: 417
  volume-title: The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours
  year: 1989
  ident: ref28
– ident: ref5
  doi: 10.1590/2359-3997000000195
– ident: ref2
  doi: 10.1111/j.1365-2265.1994.tb02486.x
– start-page: 613
  volume-title: The prevalence of pituitary adenomas: a systematic review
  year: 2004
  ident: ref30
– ident: ref8
  doi: 10.1210/jc.2010-0537
SSID ssj0000884121
Score 2.2345328
Snippet Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing...
Background Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are...
Background: Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 688
SubjectTerms epidemiology
Humans
Incidence
Original
pituitary acth hypersecretion
Pituitary ACTH Hypersecretion - epidemiology
Pituitary Neoplasms - epidemiology
prevalence
prolactinoma
Prolactinoma - epidemiology
Survival Analysis
내과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQiK8ARS6qOBHVjp3EPkLZqh8qQoJKezOOY8OqyKm2u5W48Tf4e_wSZux0u4tAXDhFip3IGdvj9-LxG0J2ORMC1mVdVrzXJeDbUHZdHWBetQ3KnduswHf6rjk8k8fTerqW6gtjwrI8cDbcnvJOCweooam1tJJb51upgEz1rm0BDKP3ZZqtkankg5WSPB26gkJR1rqZZoFNoZjYm8RTYIYVxxABtrEgJd1-WGbiPPwJcv4eObm2FB3cJXdGDElf57bfI7d8vE8-AYPMHuDK08lN3tdv1MaefliCS7jCh0YREjoE-n4OvBb8XcQYoVRtf5n-SP38_uOSvs1bN3QW6ckA0PIBOTuYfNw_LMf0CaUDFrIorRKBVy1SJGdd31TBKRuYryvHeiiBUsWc0MCBfQVILDQBsBHvbcu99d6Kh2QrDtE_JtRa3gbvgQo2tbSd7OANspedRHFmF3hBXl3b0LhRWxxTXHw1wDHQ5AZMbtDkqJHMCvJyVf0ii2r8reIb7JBVJdTCTjdghJhxhJh_jZCCvIDuNOdulp7H6-fBnM8NMIYjo3WFZyYLsnPd2wYmGO6a2OiH5aUBBg2sD4BtVZBHufdX7RESU3pJVZB2Y1xsNHizJM6-JBFvYObgTNWT__GFT8ltNFmOYHtGthbzpd8GrLTonqdp8QvBHw_H
  priority: 102
  providerName: Directory of Open Access Journals
Title Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea
URI https://www.ncbi.nlm.nih.gov/pubmed/34218648
https://www.proquest.com/docview/2548625402
https://pubmed.ncbi.nlm.nih.gov/PMC8258328
https://doaj.org/article/8ec93c1636594a41ace748027dc77974
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002728715
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Endocrinology and Metabolism, 2021, 36(3), , pp.688-696
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWq9sIFgVpK-Fi5CHEiEDtO4hxQRctWLWgrJFhpb8Zx7LJq5UB2t2pv_A3-Hr-kM066ZaHcOEWKnSgZZ2bes503hDxnSZpCXi5jzuoyBnzr4qrKHPhVkaPcue4U-EbH-eFYvJ9kkxtJod6As1upHdaTGrdnry6-X-6Cw79BximT9PXQj4DocYYr_sDeNyAp5cjDRj3SD0FZSsHCX1gcOHyclfmkU9z8-w4rGSoI-UPe8a27DYP-uZXyt9x0cI_c7UElfdt9BffJmvWb5AtQyi4knFs6vCkEe0m1r-mnBcSIc7yoVyWhjaMfW7AGBECPm4ZCt_1FmKL69ePnjL7r1nLo1NMPDWDNLTI-GH7eP4z7egqxAVoyj7VMHeMFciajTZ1zZ6R2ic24SWpogVaZmLQEUmw5QDOXOwBLrNYFs9panT4g677x9iGhWrPCWQvcMM-ErkQFdxC1qASqNRvHIvLy2obK9GLjWPPiTAHpQJMrMLlCk6NochKRF8vu3zqVjX913MMBWXZCcexwomlPVO9rSlpTpgaAZp6VQgumjS2EBP5dm6IA_hSRZzCc6tRMw_V4PGnUaauAQhypsuT4E2VEdq5HW4HH4TKK9rZZzBRQaqCBgHR5RLa70V8-TyqwxpeQESlWvouVB15t8dOvQdUbqDpEV_nof7zhY3IHTdZtaXtC1uftwj4F8DSvBmHSYRCcYxDmtq4AicgZAw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Descriptive+Epidemiology+and+Survival+Analysis+of+Prolactinomas+and+Cushing%E2%80%99s+Disease+in+Korea&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Jin+Sun+Park&rft.au=Soo+Jin+Yun&rft.au=Jung+Kuk+Lee&rft.au=So+Young+Park&rft.date=2021-06-01&rft.pub=Korean+Endocrine+Society&rft.issn=2093-596X&rft.eissn=2093-5978&rft.volume=36&rft.issue=3&rft.spage=688&rft.epage=696&rft_id=info:doi/10.3803%2FEnM.2021.1000&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_8ec93c1636594a41ace748027dc77974
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon